0001415889-23-011011.txt : 20230711 0001415889-23-011011.hdr.sgml : 20230711 20230711170639 ACCESSION NUMBER: 0001415889-23-011011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230710 FILED AS OF DATE: 20230711 DATE AS OF CHANGE: 20230711 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dable Habib J CENTRAL INDEX KEY: 0001690773 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40544 FILM NUMBER: 231082711 MAIL ADDRESS: STREET 1: C/O ACCELERON PHARMA INC. STREET 2: 128 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aerovate Therapeutics, Inc. CENTRAL INDEX KEY: 0001798749 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831377888 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 930 WINTER STREET STREET 2: SUITE M-500 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-443-2400 MAIL ADDRESS: STREET 1: 930 WINTER STREET STREET 2: SUITE M-500 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4-07112023_090734.xml X0407 4 2023-07-10 0001798749 Aerovate Therapeutics, Inc. AVTE 0001690773 Dable Habib J C/O AEROVATE THERAPEUTICS, INC. 930 WINTER STREET, SUITE M-500 WALTHAM MA 02451 true false false false 0 Stock Option (Right to Buy) 18.08 2023-07-10 4 A 0 25000 0 A 2033-07-09 Common Stock 25000 25000 D This option shall vest in 36 substantially equal monthly installments, with the first installment vesting on August 10, 2023. /s/ George A. Eldridge, Attorney-in-Fact 2023-07-11